Suppr超能文献

2012年器官移植后供体特异性HLA抗体的年度文献综述。

2012 annual literature review of donor-specific HLA antibodies after organ transplantation.

作者信息

Kaneku Hugo

机构信息

Department of Surgery, Division of Liver and Pancreas Transplantation, University of California Los Angeles, Los Angeles, California, USA.

出版信息

Clin Transpl. 2012:207-17.

Abstract

From the articles reviewed in the present chapter, we observed: 1. The frequency of de novo donor-specific human leukocyte antigen (HLA) antibodies (DSA) detection in different organs is very similar: ranging between 15% and 23% in kidney, 23% in pancreas, and 18% in intestinal transplant patients. Apparently, all organs can elicit humoral responses after transplantation at comparable rates. 2. Although rates of de novo DSA formation after kidney transplantation are very similar across different centers--between 15% and 23%--, the mean time to the first detection of de novo DSA is markedly variable between centers (from 8 months to 4 years). Some differences found in the studies that may account for this could be the age of patients (studies including pediatric patients tend to show longer time to DSA detection compared to studies only including adults patients), patients' race, and maintenance immunosuppression regimens. 3. In most organs, alloantibodies against class II HLA--and especially against HLA-DQ antigens--are the most common DSA detected. This finding supports previous studies, but the explanation remains unclear. Poor HLA-DQ matching, paucity of class II HLA antigen expression on cell surface, and technical factors related to the detection of these antibodies (mean fluorescence intensity cutoff, multiple beads with the same antigen, denatured protein on single antigen beads) are some of the potential explanations that need further investigation. 4. Recent focus on histological changes during rejection in the presence of DSA that are independent of C4d deposition may change how antibody-mediated rejection is diagnosed in the near future. 5. More studies are looking into the importance of DSA in non-kidney transplants and now evidence shows that DSA may not only affect survival and rejection rates, but may also be associated with organ-specific lesions like fibrosis and biliary complications in livers or capillaritis in lungs.

摘要

从本章回顾的文章中,我们观察到:1. 不同器官中新生供者特异性人类白细胞抗原(HLA)抗体(DSA)的检测频率非常相似:肾移植患者中为15%至23%,胰腺移植患者中为23%,肠道移植患者中为18%。显然,所有器官在移植后都能以相当的速率引发体液免疫反应。2. 尽管不同中心肾移植后新生DSA形成的速率非常相似(在15%至23%之间),但首次检测到新生DSA的平均时间在各中心之间存在显著差异(从8个月到4年)。研究中发现的一些可能解释这一现象的差异包括患者年龄(与仅纳入成年患者的研究相比,纳入儿科患者的研究往往显示DSA检测时间更长)、患者种族以及维持免疫抑制方案。3. 在大多数器官中,针对II类HLA的同种抗体——尤其是针对HLA-DQ抗原的抗体——是检测到的最常见的DSA。这一发现支持了先前的研究,但解释仍不明确。HLA-DQ匹配不佳、细胞表面II类HLA抗原表达稀少以及与这些抗体检测相关的技术因素(平均荧光强度截断值、具有相同抗原的多个微珠、单抗原微珠上的变性蛋白)是一些需要进一步研究的潜在解释。4. 近期对存在DSA时排斥反应期间组织学变化的关注,这些变化与C4d沉积无关,可能会在不久的将来改变抗体介导的排斥反应的诊断方式。5. 越来越多的研究正在探讨DSA在非肾移植中的重要性,现在有证据表明DSA不仅可能影响生存率和排斥率,还可能与器官特异性病变相关,如肝脏中的纤维化和胆道并发症或肺部的毛细血管炎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验